메뉴 건너뛰기




Volumn 186, Issue 2, 2002, Pages 181-188

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of pediatric aids clinical trials group protocol 316

(167)  Cunningham, Coleen K a   Britto, Paula b   Gelber, Richard D b   Sullivan, John L c   Dorenbaum, Alejandro d,j   Mofenson, Lynne e   Chaix, Marie Laure f   Rouzioux, Christine f,bq   Bazin, Brigitte g   Rekacewicz, Claire h   Delfraissy, Jean Francois i   Bryson, Yvonne k   Sublette, Nina l   Delke, Isaac m,w   Rathore, Mobeen m,w   Estep, Scharla n   Fiore, Simona o   Newell, Marie Louise o   Gigliotti, Maria p   Maupin, Robert q,x   more..

h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

EID: 0037099368     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341300     Document Type: Article
Times cited : (113)

References (17)
  • 1
    • 18544391179 scopus 로고    scopus 로고
    • Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185
    • (1999) J Infect Dis , vol.179 , pp. 567-575
    • Stiehm, E.R.1    Lambert, J.S.2    Mofenson, L.M.3
  • 4
    • 0033523454 scopus 로고    scopus 로고
    • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
    • (1999) Lancet , vol.354 , pp. 795-802
    • Guay, L.A.1    Musoke, P.2    Fleming, T.3
  • 7
    • 0035913939 scopus 로고    scopus 로고
    • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
    • (2001) AIDS , vol.15 , pp. 1951-1957
    • Eshleman, S.H.1    Mracna, M.2    Guay, L.A.3
  • 9
    • 0035964692 scopus 로고    scopus 로고
    • Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: A French nationwide study
    • (2001) AIDS , vol.15 , pp. 1777-1782
    • Descamps, D.1    Calvez, V.2    Izopet, J.3
  • 12
    • 0035895674 scopus 로고    scopus 로고
    • Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for the European setting
    • The Euroguidelines Group for HIV Resistance
    • (2001) AIDS , vol.15 , pp. 309-320
  • 16
    • 0035810577 scopus 로고    scopus 로고
    • Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom
    • UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance
    • (2001) BMJ , vol.322 , pp. 1087-1088
  • 17
    • 0035479290 scopus 로고    scopus 로고
    • Impact of human mission immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 Study)
    • (2001) J Infect Dis , vol.184 , pp. 914-917
    • Eshelman, S.H.1    Becket-Pergola, G.2    Deseyve, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.